Refining siRNA in vivo transfection: silencing SPHK1reveals its key role in C5a-induced inflammation in vivo

Pushparaj, P.N., H'ng, S.C. and Melendez Romero, A.J. (2008) Refining siRNA in vivo transfection: silencing SPHK1reveals its key role in C5a-induced inflammation in vivo. International Journal of Biochemistry and Cell Biology, 40(9), pp. 1817-1825. (doi:10.1016/j.biocel.2008.01.015)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/j.biocel.2008.01.015

Abstract

The transfection of siRNA in vivo is essential for the study of gene functions, target validation, and for gene therapy. However, the successful delivery of siRNA in whole organisms is still very difficult to achieve. A high-pressure delivery technique, called the “hydrodynamics” method, has been used for siRNA transfection in mice. However, it is a method based on a high-speed and high-volume of i.v. injection, which makes it very difficult to implement in vivo, due to vascular breakage. Here, we systematically investigated ways to optimize the siRNA delivery, in order to avoid strong side effects, while achieving a high-efficiency siRNA-gene knockdown. We show here that the amount of siRNA delivered is crucial, as using too little or too much siRNA minimizes the knockdown effect. We demonstrate that by carefully identifying an optimal-minimal volume, and an optimal amount of siRNA, we achieve a high knockdown effect, with a 100% survival rate. We have previously shown that SphK1 plays a key role in anaphylatoxin (C5a) signaling in neutrophils and macrophages. Our approach, optimizing the dosage of siRNA, allowed us to successfully silence our target gene-product (SphK1) in vivo, and enabled us to validate SphK1 as a key player in our in vivo model of C5a-induced acute peritonitis and systemic inflammation including multi-organ damage, demonstrating that this improved siRNA-silencing method not only allowed us to identify SphK1 as a key therapeutic target, but brings us a step closer to the usage of siRNA for therapeutic intervention.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Pushparaj, Dr Peter and Melendez Romero, Dr Alirio
Authors: Pushparaj, P.N., H'ng, S.C., and Melendez Romero, A.J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:International Journal of Biochemistry and Cell Biology
Publisher:Elsevier
ISSN:1357-2725
ISSN (Online):1878-5875
Published Online:20 January 2008
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
462311Therapeutic potential of Sphingosine Kinase blockage in allergic anaphylaxis.Alirio Melendez RomeroMedical Research Council (MRC)G0700794Institute of Infection Immunity and Inflammation